ZVR 300 (Zidovudine 300 mg)
Pill imprint ZVR 300 has been identified as Zidovudine 300 mg.
Zidovudine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for ZVR 300 (Zidovudine 300 mg)
- Imprint:
-
ZVR
300 - Strength:
- 300 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Cipla Ltd.
More resources
Zidovudine is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...


